Apr 21, 2025 02:42PM Aptevo Therapeutics (APVO) Announces 2.32M Share Offering at $0.862/sh

Apr 21, 2025 02:40PM Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 4, 2025 04:05PM Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Apr 3, 2025 08:51AM Aptevo Therapeutics (APVO) Announces $2.1M Offering at $1.19/sh

Apr 3, 2025 08:50AM Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Dec 12, 2024 12:50PM Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds

Sep 18, 2024 04:05PM Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

Sep 17, 2024 06:14AM Aptevo Therapeutics (APVO) Announces $3M Share and Warrant Offering at $0.33/sh

Sep 16, 2024 08:05PM Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

Jul 1, 2024 04:20PM Aptevo Therapeutics Announces Closing of $2.75 Million Offering

Jun 28, 2024 09:22AM Aptevo Therapeutics (APVO) Announces 5.34M Share Offering at $0.515/sh

Jun 28, 2024 09:20AM Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules

Apr 15, 2024 04:05PM Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering

Apr 11, 2024 08:05AM Aptevo Therapeutics (APVO) Prices 3.4M Share Offering at $1.35/sh

Apr 11, 2024 08:00AM Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

Nov 9, 2020 10:58AM Aptevo Therapeutics (APVO) PT Raised to $64 at Roth Capital

Mar 4, 2020 09:16AM Roth Capital Transfers Coverage on Aptevo Therapeutics (APVO) at Buy

May 24, 2019 05:04AM Roth Capital Transfers Coverage on Aptevo Therapeutics (APVO) at Buy

Apr 11, 2018 07:38AM Roth Capital Starts Aptevo Therapeutics (APVO) at Buy